Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brostallicin in Recurrent or Refractory Multiple Myeloma
NCT00060203Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Dec 2002
- Primary completion
- Mar 2003
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brostallicin in multiple myeloma (MM), sponsored by Case Comprehensive Cancer Center. Started Dec 2002; status: completed.
02
Drugs
brostallicin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00060203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060203.